Protein Based Injectable Adhesive Hydrogel
Physique temperature-activated protein-based injectable adhesive hydrogel included with decellularized adipose extracellular matrix for tissue-specific regenerative stem cell remedy
Adipose tissue engineering represents a useful various for reconstructive and beauty purposes to revive mushy tissue loss.
Herein, for the event of a tissue-engineered adipose substitute, we designed an injectable thermoresponsive tissue adhesive hydrogel by grafting bioengineered mussel adhesive protein (MAP) with poly(N-isopropylacrylamide) (PNIPAM) and incorporating decellularized adipose tissue (DAT) powder as a biochemical cue.
The physique temperature-activated PNIPAM-grafted MAP (MAP-PNIPAM) hydrogel confirmed 3.2-times greater water retention skill, excessive porosity, and eight.4-times stronger tissue adhesive properties in comparison with the PNIPAM gel alone with pore collapse.
CMV Control lentiviral particles (GFP-Puro)
Furthermore, we discovered that the introduction of 5 wt% DAT powder had adipo-inductive and adipo-conductive results, which is likely to be because of the provision of biochemical substrates enriched in collagen and laminin for cell-cell and cell-matrix interactions.
In vivo subcutaneous injection of the adipose-derived stem cell-laden DAT-incorporated MAP-PNIPAM hydrogel additional demonstrated higher quantity upkeep, angiogenesis, and lipid accumulation than management injectable alginate gel or DAT powder solely.
Collectively, our injectable physique temperature-activated tissue adhesive MAP-PNIPAM hydrogel system with a decellularized extracellular matrix supply will be utilized as a promising various for tissue-specific regenerative stem cell remedy.
Expression and identification of a novel spore wall protein in microsporidian Nosema bombycis
-
-
- Microsporidia are a bunch of obligate intracellular parasites inflicting important illness in human beings and economically necessary animals.
-
-
- Although a number of spore wall proteins (SWPs) have now been indentified in these intriguing species, the knowledge on SWPs stays too little to elucidate the spore wall formation mechanisms of microsporidia.
-
- It has been properly described that quite a few proteins with tandem repeats are typically localized on the cell wall of fungi and parasites.
-
- Beforehand, by scanning the proteins with tandem repeats in microsporidian Nosema bombycis, we obtained 83 candidate SWPs primarily based on whether or not these proteins possess a sign peptide and/or transmembrane area.
-
- Right here, we additional characterised a candidate protein (EOB13250) with three tandem repeats within the N-terminal area and a transmembrane area in C-terminus of N. bombycis. Sequence evaluation confirmed that the tandem repeat area of EOB13250 was species-specific for this parasite.
-
- RT-PCR indicated that the expression of the gene encoding this protein began on the fourth day post-infection. After cloned and expressed in E. coli, a polyclone antibody towards the recombinant EOB13250 protein was ready.
-
- Western-blotting demonstrated this protein exist in N. bombycis. Immunofluorescence evaluation (IFA) and immunoelectron microscopy evaluation (IEM) additional supplied proof that EOB13250 was an endospore wall protein.
-
- These outcomes collectively steered that EOB13250 was a novel spore wall protein of N. bombycis. This research gives an additional enrichment of the variety of recognized spore wall proteins in microsporidia and advances our understanding of the spore wall formation mechanism in these obligate unicellular parasites.
CMV Pp52 |
|||
cmv-214 | ProSpec Tany | 100µg | EUR 165 |
Description: Recombinant Cytomegalo Virus Pp52 (UL44) |
CMV Pp65 |
|||
cmv-215 | ProSpec Tany | 100µg | EUR 165 |
Description: Recombinant Cytomegalo Virus Pp65(UL83) |
CMV Pp150 |
|||
DAG1489 | Creative Diagnostics | 100 µg | EUR 774 |
CMV Pp150 |
|||
cmv-216 | ProSpec Tany | 100µg | EUR 165 |
Description: Recombinant Cytomegalo Virus Pp150(UL32) |
CMV Mosaic |
|||
cmv-217 | ProSpec Tany | 100µg | EUR 165 |
Description: Recombinant Cytomegalo Virus Mosaic |
pLenti CMV |
|||
PVT14648 | Lifescience Market | 2 ug | EUR 843.6 |
CMV Protein |
|||
abx069793-05mg | Abbexa | 0.5 mg | EUR 1053.6 |
CMV Protein |
|||
abx069794-1ml | Abbexa | 1 ml | EUR 326.4 |
CMV protein |
|||
30-1345 | Fitzgerald | 1 mg | EUR 1233 |
Description: Purified recombinant CMV protein (Grade III) |
CMV protein |
|||
30R-AC044x | Fitzgerald | 1 ml | Ask for price |
Description: Partially pure native CMV protein |
CMV protein |
|||
80-1543 | Fitzgerald | 1 mg | EUR 666 |
Description: Purified Recombinant CMV protein (gH pentamer complex) (His tag) |
CMV Protein |
|||
abx069794-25g | Abbexa | 25 g | Ask for price |
CMV Protein |
|||
abx069794-5g | Abbexa | 5 g | EUR 637.5 |
CMV Antibody |
|||
abx021636-1mg | Abbexa | 1 mg | EUR 718.8 |
CMV Antibody |
|||
abx021637-1mg | Abbexa | 1 mg | EUR 1646.4 |
CMV Antibody |
|||
abx021638-1mg | Abbexa | 1 mg | EUR 1446 |
CMV Antibody |
|||
abx021639-1mg | Abbexa | 1 mg | EUR 2798.4 |
CMV Antibody |
|||
abx021640-100ug | Abbexa | 100 ug | EUR 794.4 |
CMV Antibody |
|||
abx021641-1mg | Abbexa | 1 mg | EUR 1880.4 |
CMV Antibody |
|||
abx021642-100ug | Abbexa | 100 ug | EUR 710.4 |
CMV Antibody |
|||
abx021643-100ug | Abbexa | 100 ug | EUR 794.4 |
CMV Antibody |
|||
abx022961-1ml | Abbexa | 1 ml | EUR 878.4 |
CMV antibody |
|||
10-1439 | Fitzgerald | 200 ug | EUR 550 |
Description: Mouse monoclonal CMV antibody |
CMV antibody |
|||
10-C50C | Fitzgerald | 200 ug | EUR 345 |
Description: Mouse monoclonal CMV antibody |
CMV antibody |
|||
10-C50D | Fitzgerald | 200 ug | EUR 250 |
Description: Mouse monoclonal CMV antibody |
CMV antibody |
|||
10-C50F | Fitzgerald | 200 ug | EUR 310 |
Description: Mouse monoclonal CMV antibody |
CMV antibody |
|||
10-C50G | Fitzgerald | 200 ug | EUR 345 |
Description: Mouse monoclonal CMV antibody |
CMV antibody |
|||
10-C50L | Fitzgerald | 1 mg | EUR 100 |
Description: Mouse monoclonal CMV antibody |
CMV antibody |
|||
10-C50M | Fitzgerald | 1 mg | EUR 95 |
Description: Mouse monoclonal CMV antibody |
CMV antibody |
|||
10-C50N | Fitzgerald | 1 mg | EUR 95 |
Description: Mouse monoclonal CMV antibody |
CMV antibody |
|||
10-C50P | Fitzgerald | 200 ug | EUR 240 |
Description: Mouse monoclonal CMV antibody |
CMV antibody |
|||
10-C50R | Fitzgerald | 200 ug | EUR 195 |
Description: Mouse monoclonal CMV antibody |
CMV antibody |
|||
10R-C180a | Fitzgerald | 1 mg | EUR 383 |
Description: Mouse monoclonal CMV antibody |
CMV antibody |
|||
10C-CR1294M1 | Fitzgerald | 100 ug | EUR 135 |
Description: Mouse monoclonal CMV antibody |
CMV antibody |
|||
10C-CR2126M1 | Fitzgerald | 200 ug | EUR 275 |
Description: Mouse monoclonal CMV antibody |
CMV antibody |
|||
20-CG70 | Fitzgerald | 1 mg | EUR 115 |
Description: Goat polyclonal CMV antibody |
Cytomegalovirus (CMV) |
|||
GWB-A9C030 | GenWay Biotech | 1 ml | Ask for price |
Cytomegalovirus (CMV) |
|||
GWB-A9CB7C | GenWay Biotech | 1 ml | Ask for price |
Recombinant CMV CMV gB Protein, GST, E.coli-1mg |
|||
QP11460-1mg | EnQuireBio | 1mg | EUR 1273.2 |
Recombinant CMV CMV gB Protein, GST, E.coli-100ug |
|||
QP11460-100ug | EnQuireBio | 100ug | EUR 261.6 |
Recombinant CMV CMV gB Protein, GST, E.coli-500ug |
|||
QP11460-500ug | EnQuireBio | 500ug | EUR 795.6 |
Recombinant CMV CMV Pp52 Protein, GST, E.coli-1mg |
|||
QP11464-1mg | EnQuireBio | 1mg | EUR 1273.2 |
Recombinant CMV CMV Pp65 Protein, GST, E.coli-1mg |
|||
QP11465-1mg | EnQuireBio | 1mg | EUR 1273.2 |
Recombinant CMV CMV Pp52 Protein, GST, E.coli-100ug |
|||
QP11464-100ug | EnQuireBio | 100ug | EUR 261.6 |
Recombinant CMV CMV Pp52 Protein, GST, E.coli-500ug |
|||
QP11464-500ug | EnQuireBio | 500ug | EUR 795.6 |
Recombinant CMV CMV Pp65 Protein, GST, E.coli-100ug |
|||
QP11465-100ug | EnQuireBio | 100ug | EUR 261.6 |
Recombinant CMV CMV Pp65 Protein, GST, E.coli-500ug |
|||
QP11465-500ug | EnQuireBio | 500ug | EUR 795.6 |
CMV-p65(CMV100) Antibody |
|||
BNC810100-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV100), CF680R conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNC810100-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV100), CF680R conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNC810101-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV101), CF680R conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNC810101-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV101), CF680R conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNC430100-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV100), CF543 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNC430100-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV100), CF543 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNC430101-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV101), CF543 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNC430101-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV101), CF543 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNC050100-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV100), CF405M conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNC050100-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV100), CF405M conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNC050101-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV101), CF405M conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNC050101-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV101), CF405M conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNC550100-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV100), CF555 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNC550100-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV100), CF555 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNC550101-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV101), CF555 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNC550101-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV101), CF555 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNC610100-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV100), CF660R conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNC610100-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV100), CF660R conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNC610101-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV101), CF660R conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNC610101-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV101), CF660R conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNC800100-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV100), CF680 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNC800100-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV100), CF680 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNC800101-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV101), CF680 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNC800101-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV101), CF680 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNC700100-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV100), CF770 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNC700100-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV100), CF770 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNC700101-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV101), CF770 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNC700101-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV101), CF770 conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNCP0100-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against CMV-p65(CMV100), PerCP conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNCP0101-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against CMV-p65(CMV101), PerCP conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNCR0100-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against CMV-p65(CMV100), RPE conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNCR0101-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against CMV-p65(CMV101), RPE conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNCA0100-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against CMV-p65(CMV100), APC conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNCA0101-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against CMV-p65(CMV101), APC conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNCAP0100-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV100), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNCAP0100-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV100), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNCAP0101-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV101), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNCAP0101-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV101), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNCH0100-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV100), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV100) Antibody |
|||
BNCH0100-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV100), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNCH0101-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CMV-p65(CMV101), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CMV-p65(CMV101) Antibody |
|||
BNCH0101-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CMV-p65(CMV101), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Recombinant CMV CMV Pp28 Protein, Untagged, E.coli-1mg |
|||
QP11463-1mg | EnQuireBio | 1mg | EUR 1273.2 |
Recombinant CMV CMV Pp150 Protein, Untagged, E.coli-1mg |
|||
QP11462-1mg | EnQuireBio | 1mg | EUR 1273.2 |
Recombinant CMV CMV Pp28 Protein, Untagged, E.coli-100ug |
|||
QP11463-100ug | EnQuireBio | 100ug | EUR 261.6 |
Recombinant CMV CMV Pp28 Protein, Untagged, E.coli-500ug |
|||
QP11463-500ug | EnQuireBio | 500ug | EUR 795.6 |
Recombinant CMV CMV Pp150 Protein, Untagged, E.coli-100ug |
|||
QP11462-100ug | EnQuireBio | 100ug | EUR 261.6 |
Micro-anatomic alterations of the placenta in a non-human primate mannequin of gestational protein-restriction
Aims: Maternal protein malnutrition is related to impaired fetal development, and lifelong penalties for the offspring.
Our group has beforehand developed a mannequin of protein-restriction within the non-human primate, which was related to fetal development restriction, stillbirth, decreased placental perfusion, and proof of fetal hypoxia, suggesting perturbed vascular growth.
RNY3P2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Our goal was to histologically characterize the micro-anatomic alterations related to opposed being pregnant outcomes taking an method that allows investigation of the 3D vascular construction and surrounding histology with out the requirement for 3D vascular casting or counting on 2D stereology which each have methodological limitations.
Strategies: Rhesus macaques had been assigned within the pre-gestational interval to a management weight loss plan that contained 26% protein, or research weight loss plan containing 13% protein (50% PR weight loss plan).
RNY4P31 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Placental tissue was collected at supply and processed utilizing a clarification, immunohistochemistry, and confocal microscopy protocol printed beforehand by our group.
Three-dimensional reconstructions and quantitative evaluation of the vascular micro-anatomy was carried out utilizing evaluation software program (Imaris®) and statistical evaluation accounted for maternal and fetal confounders.
Outcomes: In unadjusted evaluation, when evaluating these pregnancies on a 50% PR weight loss plan (n = 4) with these on a management weight loss plan (n = 4), protein-restriction weight loss plan was related to decreased maternal pre-pregnancy weight (distinction of -1.975kg, 95% CI -3.267 to -0.6826).
When controlling for maternal pre-pregnancy weight, fetal intercourse, and latency from tissue assortment to imaging, a gestational protein-restriction weight loss plan was related to decreases in complete vascular size, complete vascular floor space, complete vascular quantity, and vascular density.
OPCD00958-200UG - A1AGP Recombinant Protein |
|||
OPCD00958-200UG | Aviva Systems Biology | 200ug | EUR 709 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
20-abx129955 | Abbexa |
|
|
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
20-abx130174 | Abbexa |
|
|
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
20-abx130175 | Abbexa |
|
|
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
20-abx175329 | Abbexa |
|
|
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
20-abx171163 | Abbexa |
|
|
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
20-abx171164 | Abbexa |
|
|
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
20-abx102589 | Abbexa |
|
|
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
20-abx102590 | Abbexa |
|
|
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
20-abx102591 | Abbexa |
|
|
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
20-abx102592 | Abbexa |
|
|
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx129955-100l | Abbexa | 100 µl | EUR 287.5 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx129955-1ml | Abbexa | 1 ml | EUR 812.5 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx129955-200l | Abbexa | 200 µl | EUR 362.5 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx130174-100l | Abbexa | 100 µl | EUR 262.5 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx130174-1ml | Abbexa | 1 ml | EUR 725 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx130174-200l | Abbexa | 200 µl | EUR 337.5 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx130175-100l | Abbexa | 100 µl | EUR 262.5 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx130175-1ml | Abbexa | 1 ml | EUR 725 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx130175-200l | Abbexa | 200 µl | EUR 337.5 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx102589-100l | Abbexa | 100 µl | EUR 250 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx102589-1ml | Abbexa | 1 ml | EUR 675 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx102589-200l | Abbexa | 200 µl | EUR 312.5 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx102590-100l | Abbexa | 100 µl | EUR 262.5 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx102590-1ml | Abbexa | 1 ml | EUR 687.5 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx102590-200l | Abbexa | 200 µl | EUR 325 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx102591-100l | Abbexa | 100 µl | EUR 262.5 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx102591-1ml | Abbexa | 1 ml | EUR 725 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx102591-200l | Abbexa | 200 µl | EUR 337.5 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx102592-100l | Abbexa | 100 µl | EUR 287.5 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx102592-1ml | Abbexa | 1 ml | EUR 812.5 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx102592-200l | Abbexa | 200 µl | EUR 362.5 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx171163-100l | Abbexa | 100 µl | EUR 850 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx171163-1ml | Abbexa | 1 ml | Ask for price |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx171163-200l | Abbexa | 200 µl | Ask for price |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx171164-1ml | Abbexa | 1 ml | EUR 850 |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx342028-100l | Abbexa | 100 µl | Ask for price |
Alpha-1-Acid Glycoprotein (a1AGP) Antibody |
|||
abx342028-50l | Abbexa | 50 µl | EUR 2575 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU53817-100ug | Biomatik Corporation | 100ug | EUR 564.3 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU53817-1mg | Biomatik Corporation | 1mg | EUR 2501.2 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU53817-50ug | Biomatik Corporation | 50ug | EUR 453.2 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU40163-100ug | Biomatik Corporation | 100ug | EUR 591.8 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU40163-1mg | Biomatik Corporation | 1mg | EUR 2620.8 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU40163-50ug | Biomatik Corporation | 50ug | EUR 475.2 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU40164-100ug | Biomatik Corporation | 100ug | EUR 443.3 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU40164-1mg | Biomatik Corporation | 1mg | EUR 1747.2 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU40164-50ug | Biomatik Corporation | 50ug | EUR 268.8 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU40165-100ug | Biomatik Corporation | 100ug | EUR 393.8 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU40165-1mg | Biomatik Corporation | 1mg | EUR 1747.2 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU40165-50ug | Biomatik Corporation | 50ug | EUR 316.8 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU40166-100ug | Biomatik Corporation | 100ug | EUR 504.9 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU53918-100ug | Biomatik Corporation | 100ug | EUR 566.5 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU53918-1mg | Biomatik Corporation | 1mg | EUR 2511.6 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU53918-50ug | Biomatik Corporation | 50ug | EUR 455.4 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU40166-1mg | Biomatik Corporation | 1mg | EUR 2238.6 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU40166-50ug | Biomatik Corporation | 50ug | EUR 405.9 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU40167-100ug | Biomatik Corporation | 100ug | EUR 504.9 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU40167-1mg | Biomatik Corporation | 1mg | EUR 2238.6 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU40167-50ug | Biomatik Corporation | 50ug | EUR 405.9 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU56833-100ug | Biomatik Corporation | 100ug | EUR 470.4 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU56833-1mg | Biomatik Corporation | 1mg | EUR 2184 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU56833-50ug | Biomatik Corporation | 50ug | EUR 385 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU54604-100ug | Biomatik Corporation | 100ug | EUR 616 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU54604-1mg | Biomatik Corporation | 1mg | EUR 2730 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPU54604-50ug | Biomatik Corporation | 50ug | EUR 495 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPA816Bo01 | Cloud-Clone | 10ug | EUR 192 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
4-RPA816Bo01 | Cloud-Clone |
|
|
Description: Recombinant Bovine Alpha-1-Acid Glycoprotein expressed in: E.coli |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPA816Hu01 | Cloud-Clone | 10ug | EUR 112 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
4-RPA816Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Alpha-1-Acid Glycoprotein expressed in: E.coli |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPA816Mu01 | Cloud-Clone | 10ug | EUR 128 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
4-RPA816Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Alpha-1-Acid Glycoprotein expressed in: E.coli |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPA816Po01 | Cloud-Clone | 10ug | EUR 183 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
4-RPA816Po01 | Cloud-Clone |
|
|
Description: Recombinant Pig Alpha-1-Acid Glycoprotein expressed in: E.coli |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPA816Ra01 | Cloud-Clone | 10ug | EUR 184 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
4-RPA816Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Alpha-1-Acid Glycoprotein expressed in: E.coli |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPA816Ra02 | Cloud-Clone | 10ug | EUR 164 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
4-RPA816Ra02 | Cloud-Clone |
|
|
Description: Recombinant Rat Alpha-1-Acid Glycoprotein expressed in: E.coli |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
RPA816Ra03 | Cloud-Clone | 10ug | EUR 164 |
Recombinant Alpha-1-Acid Glycoprotein (a1AGP) |
|||
4-RPA816Ra03 | Cloud-Clone |
|
|
Description: Recombinant Rat Alpha-1-Acid Glycoprotein expressed in: E.coli |